Secular Trends in the Incidence of Cholangiocarcinoma in the USA and the Impact of Misclassification

Digestive Diseases and Sciences

Volumn 59, Issue 12, 2014, Pages 3103-3110

  Tyson, Gia L ^a,b,e   Ilyas, Jawad A ^a,b   Duan, Zhigang ^a,b   Green, Linda K ^c   Younes, Mamoun ^d   El Serag, Hashem B ^a,b   Davila, Jessica A ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^e NONE   (United States)

Author keywords

Bile duct cancer; Epidemiology; Liver cancer; Misclassification

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; DATA BASE; DISEASE CLASSIFICATION; FEMALE; GROWTH; HUMAN; INCIDENCE; KLATSKIN TUMOR; MAJOR CLINICAL STUDY; MALE; POISSON DISTRIBUTION; RACE; TREND STUDY; UNITED STATES; ANCESTRY GROUP; BILE DUCT NEOPLASMS; CHOLANGIOCARCINOMA; CLASSIFICATION; EPIDEMIOLOGY; INTRAHEPATIC BILE DUCT; KLATSKIN'S TUMOR; MIDDLE AGED; PATHOLOGY; REGISTER; TIME;

AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; CONTINENTAL POPULATION GROUPS; FEMALE; HUMANS; INCIDENCE; KLATSKIN'S TUMOR; MALE; MIDDLE AGED; REGISTRIES; TIME FACTORS; UNITED STATES;

EID: 84912104904     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-014-3276-2     Document Type: Article

References (19)

1. Blechacz BR, Gores GJ. Cholangiocarcinoma. Clin Liver Dis. 2008;12:131–50, ix.
2. Gatto M, Bragazzi MC, Semeraro R, et al. Cholangiocarcinoma: update and future perspectives. Dig Liver Dis. 2010;42:253–260.
3. Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis. 2004;24:115–125.
4. Tyson GL, El-Serag HB. Risk factors for cholangiocarcinoma. Hepatology. 2011;54:173–184.
5. Patel T. Cholangiocarcinoma. Nat Clin Pract Gastroenterol Hepatol. 2006;3:33–42.
6. Khan SA, Toledano MB, Taylor-Robinson SD. Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford). 2008;10:77–82.
7. Patel T. Worldwide trends in mortality from biliary tract malignancies. BMC Cancer. 2002;2:10.
8. Khan SA, Taylor-Robinson SD, Toledano MB, Beck A, Elliott P, Thomas HC. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol. 2002;37:806–813.
9. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology. 2001;33:1353–1357.
10. Welzel TM, McGlynn KA, Hsing AW, O’Brien TR, Pfeiffer RM. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst. 2006;98:873–875.
11. Carriaga MT, Henson DE. Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer. 1995;75:171–190.
12. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) Research Data (1973-2007), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2010, based on the November 2009 submission. 2011.
13. Adamo MD, Johnson CH, Ruhl JL, Dickie LA. 2012 SEER Program Coding and Staging Manual. National Cancer Institute, NIH; 2012.
14. Khan SA, Emadossadaty S, Ladep NG, et al. Rising trends in cholangiocarcinoma: is the ICD classification system misleading us? J Hepatol. 2012;56:848–854.
15. Shaib YH, El-Serag HB, Davila JA, Morgan R, McGlynn KA. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology. 2005;128:620–626.
16. Shaib YH, El-Serag HB, Nooka AK, et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study. Am J Gastroenterol. 2007;102:1016–1021.
17. Shin HR, Oh JK, Lim MK, et al. Descriptive epidemiology of cholangiocarcinoma and clonorchiasis in Korea. J Korean Med Sci. 2010;25:1011–1016.
18. Welzel TM, Graubard BI, El-Serag HB, et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol. 2007;5:1221–1228.
19. Bertuccio P, Bosetti C, Levi F, Decarli A, Negri E, La Vecchia C. A comparison of trends in mortality from primary liver cancer and intrahepatic cholangiocarcinoma in Europe. Ann Oncol. 2013;24:1667–1674.